Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_assertion type Assertion NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_head.
- NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_assertion description "[Utilizing a database of 855 colon and rectal cancers in two prospective cohort studies (the Nurses' Health Study and the Health Professionals Follow-up Study), we detected MGMT promoter hypermethylation in 325 tumors (38%) by MethyLight and loss of MGMT expression in 37% (247/672) of tumors by immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_provenance.
- NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_assertion evidence source_evidence_literature NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_provenance.
- NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_assertion SIO_000772 21140203 NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_provenance.
- NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_assertion wasDerivedFrom befree-20150227 NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_provenance.
- NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_assertion wasGeneratedBy ECO_0000203 NP555174.RAmoATZ8FXPC62M6F1E3wb3RC3DMxixg_inpNbhjnZcyA130_provenance.